US Bancorp’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-600
| Closed | -$17K | – | 3740 |
|
|
2018
Q4 | $17K | Hold |
600
| – | – | ﹤0.01% | 2885 |
|
|
2018
Q3 | $17K | Hold |
600
| – | – | ﹤0.01% | 2978 |
|
|
2018
Q2 | $17K | Hold |
600
| – | – | ﹤0.01% | 2996 |
|
|
2018
Q1 | $15K | Sell |
600
-2,044
| -77% | -$49.7K | ﹤0.01% | 3049 |
|
|
2017
Q4 | $64K | Sell |
2,644
-1,867
| -41% | -$49.2K | ﹤0.01% | 2476 |
|
|
2017
Q3 | $125K | Buy |
4,511
+541
| +14% | +$14.4K | ﹤0.01% | 2115 |
|
|
2017
Q2 | $100K | Sell |
3,970
-623
| -14% | -$15.4K | ﹤0.01% | 2194 |
|
|
2017
Q1 | $124K | Sell |
4,593
-2,794
| -38% | -$77.2K | ﹤0.01% | 2054 |
|
|
2016
Q4 | $193K | Buy |
7,387
+3,394
| +85% | +$83.9K | ﹤0.01% | 1805 |
|
|
2016
Q3 | $100K | Sell |
3,993
-3,890
| -49% | -$90.7K | ﹤0.01% | 2088 |
|
|
2016
Q2 | $171K | Sell |
7,883
-305
| -4% | -$5.44K | ﹤0.01% | 1767 |
|
|
2016
Q1 | $123K | Sell |
8,188
-4,586
| -36% | -$76.8K | ﹤0.01% | 1911 |
|
|
2015
Q4 | $280K | Sell |
12,774
-7,782
| -38% | -$145K | ﹤0.01% | 1552 |
|
|
2015
Q3 | $324K | Buy |
20,556
+3,102
| +18% | +$49.7K | ﹤0.01% | 1499 |
|
|
2015
Q2 | $249K | Buy |
17,454
+3,086
| +21% | +$52.3K | ﹤0.01% | 1670 |
|
|
2015
Q1 | $249K | Sell |
14,368
-1,916
| -12% | -$33.9K | ﹤0.01% | 1701 |
|
|
2014
Q4 | $292K | Sell |
16,284
-1,634
| -9% | -$26.3K | ﹤0.01% | 1592 |
|
|
2014
Q3 | $235K | Sell |
17,918
-9,565
| -35% | -$129K | ﹤0.01% | 1679 |
|
|
2014
Q2 | $395K | Buy |
27,483
+217
| +0.8% | +$2.83K | ﹤0.01% | 1465 |
|
|
2014
Q1 | $347K | Buy |
27,266
+12,137
| +80% | +$158K | ﹤0.01% | 1506 |
|
|
2013
Q4 | $151K | Buy |
15,129
+1,736
| +13% | +$19.7K | ﹤0.01% | 1877 |
|
|
2013
Q3 | $176K | Buy |
13,393
+4,530
| +51% | +$59.4K | ﹤0.01% | 1752 |
|
|
2013
Q2 | $127K | Buy |
+8,863
| New | +$111K | ﹤0.01% | 1897 |
|
Other funds holding NXTM
US Bancorp's NXTM Position: Q1 2019 in Review
US Bancorp sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 600 shares — an estimated $17K sold.
US Bancorp first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $395K in Q2 2014. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- US Bancorp reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- US Bancorp sold 600 NxStage Medical Inc. shares in Q1 2019, an estimated $17K.
- US Bancorp first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- US Bancorp's NxStage Medical Inc. position peaked at $395K in Q2 2014.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on US Bancorp's 13F filing for Q1 2019, filed 8 May 2019.